TS Financial Group (TSFG)’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 752 |
|
|
2025
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 747 |
|
|
2024
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 692 |
|
|
2024
Q3 | $2K | Sell |
50
-50
| -50% | -$2K | ﹤0.01% | 677 |
|
|
2024
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 589 |
|
|
2024
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 580 |
|
|
2023
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 631 |
|
|
2023
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 741 |
|
|
2023
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 744 |
|
|
2023
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 678 |
|
|
2022
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 683 |
|
|
2022
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 706 |
|
|
2022
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 712 |
|
|
2022
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 697 |
|
|
2021
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 680 |
|
|
2021
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 644 |
|
|
2021
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 693 |
|